Medicare Enrolled
Muhammad Rashad
Pulmonary Disease · Charlotte, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Rashad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Rashad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Rashad
Muhammad Rashad is a pulmonary disease specialist in Charlotte, NC, with 17 years of NPI registration. Based on federal Medicare data, Rashad performed 2,262 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Rashad received a total of $10,597 from 38 pharmaceutical and/or device companies across 325 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Rashad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 12% volume in NC
$10,597 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,262
Medicare services
Top 12% in NC for pulmonary disease
Not available
Unique patients (not deduplicated)
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
773 | $89 | $235 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
333 | $59 | $223 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
218 | $62 | $160 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
140 | $25 | $180 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
109 | $118 | $341 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
89 | $41 | $175 |
| Inpatient or observation ventilation management Follow-up care for a patient receiving ventilator support during an inpatient stay or observation period. This service involves the ongoing management and adjustment of breathing assistance. |
86 | $48 | $196 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
76 | $92 | $296 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
65 | $9 | $25 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
52 | $20 | $111 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
47 | $39 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
44 | $131 | $552 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
44 | $164 | $1,183 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
24 | $37 | $665 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
19 | $68 | $75 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $137 | $300 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
18 | $29 | $30 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
17 | $70 | $256 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
17 | $49 | $150 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
17 | $26 | $125 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
16 | $126 | $566 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $94 | $400 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
13 | $39 | $619 |
| Placement of radiation therapy markers in lung airways A procedure where small markers are placed into the airways of the lung using an endoscope to assist with radiation therapy targeting. |
12 | $78 | $585 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,597
Total received (2018-2024)
Avg $1,514/year across 7 years
Top 15% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
325
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,852
2023
$1,919
2022
$5,495
2021
$865
2020
$111
2019
$309
2018
$45
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$460
GlaxoSmithKline, LLC.
$189
United Therapeutics Corporation
$144
Insmed, Inc.
$121
Actelion Pharmaceuticals US, Inc.
$121
Regeneron Healthcare Solutions, Inc.
$116
Boehringer Ingelheim Pharmaceuticals, Inc.
$109
GENZYME CORPORATION
$91
Mallinckrodt Hospital Products Inc.
$86
Grifols USA, LLC
$47
INOGEN, INC.
$45
Takeda Pharmaceuticals U.S.A., Inc.
$43
ANI Pharmaceuticals, Inc.
$41
Mylan Specialty L.P.
$39
HARMONY BIOSCIENCES LLC
$34
Merck Sharp & Dohme LLC
$33
Baxter Healthcare
$29
Axsome Therapeutics, Inc.
$27
Novartis Pharmaceuticals Corporation
$23
Philips North America LLC
$20
ABBVIE INC.
$17
Amgen Inc.
$15
Top 3 companies account for 42.8% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$4,714
AstraZeneca Pharmaceuticals LP
$1,207
GlaxoSmithKline, LLC.
$746
Boehringer Ingelheim Pharmaceuticals, Inc.
$431
United Therapeutics Corporation
$416
Mallinckrodt Hospital Products Inc.
$392
Insmed, Inc.
$284
Regeneron Healthcare Solutions, Inc.
$264
GENZYME CORPORATION
$263
Electromed, Inc.
$227
Actelion Pharmaceuticals US, Inc.
$222
Mylan Specialty L.P.
$158
Novartis Pharmaceuticals Corporation
$135
Philips Electronics North America Corporation
$104
Takeda Pharmaceuticals U.S.A., Inc.
$103
HARMONY BIOSCIENCES LLC
$87
Grifols USA, LLC
$77
Baxter Healthcare
$73
Inogen, Inc.
$70
JAZZ PHARMACEUTICALS INC.
$68
Amgen Inc.
$63
Axsome Therapeutics, Inc.
$59
Merck Sharp & Dohme LLC
$54
INOGEN, INC.
$45
Genentech USA, Inc.
$43
ANI Pharmaceuticals, Inc.
$41
Apria Healthcare LLC
$32
Eisai Inc.
$30
Resmed Corp
$24
AbbVie Inc.
$22
Merck Sharp & Dohme Corporation
$22
Harmony Biosciences LLC
$22
Philips North America LLC
$20
Avadel CNS Pharmaceuticals, LLC
$19
ABBVIE INC.
$17
Gilead Sciences, Inc.
$17
EKOS Corporation
$16
Alexion Pharmaceuticals, Inc.
$13
Top 3 companies account for 62.9% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AVYCAZ · AirSense · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · COMBIVENT RESPIMAT · DUPIXENT · Da Vinci Surgical System · Dayvigo · EKOSONIC · ENTRESTO · Esbriet · FASENRA · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INOGEN · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ION · InogenOne · KEYTRUDA · LUMRYZ · Medela · NUCALA · OFEV · OPSUMIT · ORENITRAM · PURIFIED CORTROPHIN GEL · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · ULTOMIRIS · UPTRAVI · WAKIX · WINREVAIR · Wakix · XOLAIR · XYWAV · Xembify · Xolair · YUPELRI · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
36
County median income
$83,765
Nearest hospital to ZIP centroid (approximate)
CAROLINAS MEDICAL CENTER/BEHAV HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Rashad is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NC), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Rashad experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Rashad performed 773 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Rashad receive payments from pharmaceutical companies?
Yes. Rashad received a total of $10,597 from 38 companies across 325 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Rashad's costs compare to other pulmonary diseases in Charlotte?
Rashad's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Rashad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Charlotte
Browse pulmonary diseases in Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NC
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NC
Which NC pulmonary diseases receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology